Distribution of Cerebrospinal Fluid Biomarker Profiles in Patients Explored for Cognitive Disorders-Reference-Cited by-同舟云学术

Distribution of Cerebrospinal Fluid Biomarker Profiles in Patients Explored for Cognitive Disorders

Published:2018-07-03 Issue:3 Volume:64 Page:889-897
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Paquet Claire¹²,Bouaziz-Amar Elodie³,Cognat Emmanuel¹²,Volpe-Gillot Lisette⁴,Haddad Victor⁵,Mahieux Florence⁶,Dekimeche Siham⁷,Defontaines Benedicte⁸,Chabriat Hugues⁹,Belin Catherine¹⁰,Texeira Antonio¹¹,Goutagny Stephane¹²,Questel Frank¹³,Azuar Julien¹³,Sellier Pierre-Olivier¹⁴,Laplanche Jean-Louis³,Hugon Jacques¹²,Dumurgier Julien¹²

Affiliation:

1. Cognitive Neurology Center, Lariboisière – Fernand Widal Hospital, AP-HP, Paris, France

2. Inserm U942, Universite Paris Diderot, Sorbonne Paris Cité, Paris, France

3. Department of Biochemistry, Lariboisière – Fernand Widal Hospital, AP-HP, Paris, France

4. Department of Neurology, Leopold Bellan Hospital, Paris, France

5. Department of Geriatrics, Saint Camille Hospital, Bry-sur-Marnes, France

6. Department of Geriatrics, Sainte-Perrine Hospital, Paris, France

7. Departmentof Geriatrics, Les Gonesses Hospital, Gonesses, France

8. Alois Network, Paris, France

9. Department of Neurology, Lariboisière – Fernand Widal Hospital, AP-HP, Paris, France

10. Department of Neurology, Avicennes Hospital, Paris, France

11. Department of Geriatrics, Lariboisière – Fernand Widal Hospital, AP-HP, Paris, France

12. Department of Neurosurgery, Beaujon Hospital, AP-HP, Clichy, France.

13. Department of Psychiatry, Lariboisière – Fernand Widal Hospital, AP-HP, Paris, France

14. Department of Internal Medicine, Lariboisière – Fernand Widal Hospital, AP-HP, Paris, France

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference40 articles.

1. The global prevalence of dementia: A systematic review and metaanalysis.;Prince;Alzheimers Dement,2013

2. National Institute onAging-Alzheimer’s Association guidelines for theneuropathologic assessment of Alzheimer’s disease.;Hyman;Alzheimers Dement,2012

3. Reproducibility of Alzheimer’s disease cerebrospinal fluid-biomarkermeasurements under clinical routine conditions.;Vogelgsang;J Alzheimers Dis,2018

4. Concordance between cerebrospinal fluid biomarkers with Alzheimer’s disease pathology between three independent assay platforms.;Doecke;J Alzheimers Dis,2018

5. Cost-utility of using Alzheimer’sdisease biomarkers in cerebrospinal fluid to predict progression from mild cognitive impairment to dementia.;Handels;J Alzheimers Dis,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between ATN profiles and mortality in a clinical cohort of patients with cognitive disorders;Alzheimer's Research & Therapy;2023-04-10

2. Association of cognitive function with Neurofilament light chain in the aqueous humor of human eye;Frontiers in Aging Neuroscience;2022-11-03

3. Alzheimer’s Disease Diagnosis Based on the Amyloid, Tau, and Neurodegeneration Scheme (ATN) in a Real-Life Multicenter Cohort of General Neurological Centers;Journal of Alzheimer's Disease;2022-10-25

4. Cerebrospinal Fluid Biomarkers in Patients With Alcohol Use Disorder and Persistent Cognitive Impairment;Alcoholism: Clinical and Experimental Research;2021-02-19

5. Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease;Neurobiology of Aging;2019-07